In the case of anti-TNF treatment for inflammatory bowel disease (IBD), would there be a safer, equally effective form of this protein class that might be restricted to the intestinal lamina propria following oral delivery as has been suggested [28]? The gene discussed is TNF; the disease is inflammatory bowel disease.